Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Combination Checkpoint Inhibitor Plus Erlotinib or Crizotinib for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT01998126. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase II Study of AZD9291 in Advanced Stage NSCLC With EGFR and T790M Mutations Detected in Plasma Ct-DNA
ClinicalTrials.gov study NCT02811354. IPD Sharing: UNDECIDED. Countries: 5. Publications: 2.
First Line Osimertinib for EGFR Mutation-positive Non-Small Cell Lung Cancer in Real World Chinese Setting
ClinicalTrials.gov study NCT04391283. IPD Sharing: NO. Countries: 1. Publications: 10.
Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation
ClinicalTrials.gov study NCT02737774. IPD Sharing: NO. Countries: 1. Publications: 3.
Study of EGFR TKI in Patients With Advanced NSCLC Harbouring EGFR Mutations
ClinicalTrials.gov study NCT06062823. IPD Sharing: NO. Countries: 1. Publications: 18.
Icotinib Versus Placebo as Adjuvant Therapy in EGFR-mutant Lung Adenocarcinoma
ClinicalTrials.gov study NCT02125240. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumors With NRG1/ERBB Gene Fusions
ClinicalTrials.gov study NCT03805841. IPD Sharing: NO. Countries: 3. Publications: 1.
Osimertinib in Subjects With Advanced Non-Small Cell Lung Cancer EGFR-T790M Mutation-positive
ClinicalTrials.gov study NCT03790397. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients
ClinicalTrials.gov study NCT01749072. IPD Sharing: Not stated. Countries: 1. Publications: 5.
CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM
ClinicalTrials.gov study NCT05168423. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Toripalimab Plus Pemetrexed+Platinus in Advanced Non-small-cell Lungcancer Patients Previsouly Treated EGFR-TKI
ClinicalTrials.gov study NCT03924050. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT01542437. IPD Sharing: NO. Countries: 1. Publications: 29.
Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation
ClinicalTrials.gov study NCT01929200. IPD Sharing: Not stated. Countries: 1. Publications: 2.
EGFR-TKIs Combine With Anlotinib as First-line Treatment for Patients With Advanced EGFR Mutation-positive NSCLC
ClinicalTrials.gov study NCT03720873. IPD Sharing: YES. Countries: 1. Publications: 0.
High-dose Furmonertinib for First-line Treatment of EGFR Mutated NSCLC With Central Nervous System (CNS) Metastases
ClinicalTrials.gov study NCT05379803. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sunvozertinib (DZD9008) in Pretreated Lung Cancer Patients with EGFR Exon20 Insertion Mutation (WU-KONG6)
ClinicalTrials.gov study NCT05712902. IPD Sharing: NO. Countries: 1. Publications: 1.
Real-world Analysis of Workup at Disease Progression and Implementation of Osimertinib for EGFR+ NSCLC
ClinicalTrials.gov study NCT04105153. IPD Sharing: Not stated. Countries: 1. Publications: 5.
A Study of Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR Mutations
ClinicalTrials.gov study NCT02824458. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
Evaluating Preventive Therapy With Oint Threolone, Synthomycine or Aqua Cream, for EGFR'I Induced Acneiform Rash
ClinicalTrials.gov study NCT01256437. IPD Sharing: YES. Countries: 1. Publications: 2.
First-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R Mutations
ClinicalTrials.gov study NCT05271916. IPD Sharing: YES. Countries: 1. Publications: 12.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.